157 related articles for article (PubMed ID: 36226249)
1. Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway.
Wang M; Zhang Q; Li Y; Jin L; Fang Z
J Oncol; 2022; 2022():5824617. PubMed ID: 36226249
[TBL] [Abstract][Full Text] [Related]
2. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
[TBL] [Abstract][Full Text] [Related]
4. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
5. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
7. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
[TBL] [Abstract][Full Text] [Related]
8. Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.
Kilgore J; Jackson AL; Clark LH; Guo H; Zhang L; Jones HM; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
Am J Transl Res; 2016; 8(6):2705-15. PubMed ID: 27398153
[TBL] [Abstract][Full Text] [Related]
9. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
10. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
11. Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma.
Zhuo Z; Wang A; Yu H
Arch Gynecol Obstet; 2016 Nov; 294(5):1055-1061. PubMed ID: 27402506
[TBL] [Abstract][Full Text] [Related]
12. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
Feng M; Dong N; Zhou X; Ma L; Xiang R
Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
14. Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1.
Wang Y; Wang G; Liu Y; Yang F; Zhang H; Kong Y
Phytomedicine; 2023 Nov; 120():155062. PubMed ID: 37683586
[TBL] [Abstract][Full Text] [Related]
15. High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
Wallbillich JJ; Josyula S; Saini U; Zingarelli RA; Dorayappan KD; Riley MK; Wanner RA; Cohn DE; Selvendiran K
PLoS One; 2017; 12(1):e0170318. PubMed ID: 28114390
[TBL] [Abstract][Full Text] [Related]
16. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
[TBL] [Abstract][Full Text] [Related]
17. Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Cancer Cell Int; 2014; 14():53. PubMed ID: 24966801
[TBL] [Abstract][Full Text] [Related]
18. Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.
Gu CJ; Cheng J; Zhang B; Yang SL; Xie F; Sun JS; Huang LQ; Yu JJ; Li MQ
Am J Transl Res; 2017; 9(9):4071-4082. PubMed ID: 28979682
[TBL] [Abstract][Full Text] [Related]
19. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and
Roque DR; Zhang L; Wysham WZ; Han J; Sun W; Yin Y; Livingston JN; Batchelor KW; Zhou C; Bae-Jump VL
Front Oncol; 2021; 11():690435. PubMed ID: 34422646
[TBL] [Abstract][Full Text] [Related]
20. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway.
Li Y; Zhang S; Wang Y; Peng J; Fang F; Yang X
BMC Cancer; 2018 Dec; 18(1):1294. PubMed ID: 30594176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
